Group 1: Stock Split Overview - A high-profile electric-vehicle (EV) manufacturer, Lucid Group, has announced a 1-for-10 reverse stock split, consolidating over 3 billion outstanding shares to approximately 307.3 million [6][10] - The reverse stock split will increase Lucid's share price from $1.98 to $19.80 when trading commences [10] - Reverse stock splits are generally viewed negatively by investors, as they often indicate underlying operational struggles [5][7] Group 2: Company Performance and Challenges - Lucid Group's stock has declined nearly 97% since its all-time high in early 2021, reflecting significant operational challenges [11] - The company has consistently lowered its production forecasts, with a 2024 estimate dropping from 90,000 units to just 9,000 [16] - Supply chain issues and delays in launching new models, such as the Gravity SUV, have further hampered Lucid's ability to scale production [17][18] Group 3: Financial Position - Despite operational losses, Lucid Group ended June with over $2.8 billion in cash and investments, supported by Saudi Arabia's Public Investment Fund [19] - The company reported a loss of over $1.5 billion in the first half of 2025 and has accumulated losses of $13.8 billion since inception [19] - There are no immediate solvency issues, but the company has burned through $1.26 billion in cash from operations in just six months [19]

Core Points - MSP Recovery, Inc. will implement a reverse stock split of its Class A common stock at a ratio of 1-for-7, effective at 11:59 P.M. on September 1, 2025, to comply with Nasdaq's minimum bid price requirement of $1.00 per share [1][3] - The company's common stock will continue to trade on the Nasdaq Capital Market under the symbol "MSPR" and will begin trading on a split-adjusted basis on September 2, 2025 [2][4] - Following the reverse split, approximately 1.02 million shares of Class A common stock will be issued and outstanding [4] Company Overview - MSP Recovery, founded in 2014, specializes in Medicare, Medicaid, commercial, and secondary payer reimbursement recovery, utilizing data-driven solutions to improve the healthcare reimbursement system [5]

Core Points - MSP Recovery, Inc. will implement a reverse stock split of its Class A common stock at a ratio of 1-for-7, effective September 1, 2025, to comply with Nasdaq's minimum bid price requirement of $1.00 per share [1][3] - The reverse stock split has been approved by the Company's stockholders, and the new CUSIP number for the Class A common stock will be 553745-40-7 [2][3] - Following the reverse split, approximately 1.02 million shares of Class A common stock will be issued and outstanding, with trading on a split-adjusted basis commencing on September 2, 2025 [4] Company Overview - MSP Recovery, founded in 2014, specializes in Medicare, Medicaid, commercial, and secondary payer reimbursement recovery, utilizing data-driven solutions to improve the healthcare reimbursement system [5]

Core Viewpoint - SEGG Media Corporation has announced a 1-for-10 reverse stock split aimed at strengthening its foundation for growth and attracting institutional investors, effective August 29, 2025 [1][2]. Group 1: Strategic Objectives - The reverse stock split is part of a deliberate structural strategy to enhance institutional engagement and create long-term value for shareholders [2][3]. - The company aims to achieve three strategic growth objectives through this reverse stock split [3][11]. Group 2: Growth and Acquisitions - The reverse stock split is expected to bolster SEGG Media's capacity for strategic acquisitions, including Veloce Media Group and Nook Holdings, while accelerating operational expansion and revenue growth in the entertainment and gaming sectors [6][7]. - The company has secured commitments of $450 million from United Capital Investments London Limited and Generating Alpha Ltd to support its growth initiatives [5]. Group 3: Market Positioning - The proactive nature of the reverse stock split distinguishes SEGG Media from companies that are forced to undertake such measures to maintain their listings, reflecting a successful turnaround strategy [5]. - The company aims to enhance institutional and algorithmic access by targeting a higher sustained share price, which will attract a broader base of institutional investors and improve trading conditions [11]. Group 4: Market Structure and Manipulation Mitigation - A higher share price range is expected to strengthen market structure by engaging top-tier market makers, leading to improved liquidity and trading volumes [11]. - The reverse stock split and associated CUSIP change are intended to mitigate market manipulation risks, reinforcing the company's measures against short-selling activities [11].

As filed with the United States Securities and Exchange Commission on August 26, 2025 Registration No. 333-289229 Amendment No.1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aureus Greenway Holdings Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Nevada 7997 99-0418678 (I.R.S. Employer Identification Number) 2995 Remington Boulevard Kissimmee, Florida 347 ...

Core Points - Plus Therapeutics, Inc. has confirmed compliance with Nasdaq Listing Rule 5550(b), meeting both the Market Value of Listing Securities (MVLS) standard of at least $35 million and the stockholders' equity threshold of at least $2.5 million [1][2] - Nasdaq has granted Plus Therapeutics an extension until November 12, 2025, to regain compliance with the $1.00 bid price rule, previously set for September 8, 2025 [2] - The company is under a one-year monitoring period for the Equity Standard, which will last until August 22, 2026, during which it must maintain compliance to avoid delisting [3] Company Overview - Plus Therapeutics is a clinical-stage pharmaceutical company based in Houston, Texas, focused on developing targeted radiotherapeutics for central nervous system cancers [4] - The company employs advanced technologies combining image-guided local beta radiation and targeted drug delivery, with key programs targeting leptomeningeal metastases and recurrent glioblastoma [4] - Plus Therapeutics has established a supply chain through strategic partnerships to support the development, manufacturing, and potential commercialization of its products [4]

Core Viewpoint - DarioHealth Corp. is implementing a 20-for-1 reverse stock split of its common stock, effective August 28, 2025, to enhance its stock price and maintain compliance with Nasdaq listing requirements [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of outstanding shares from approximately 47,996,572 to about 2,399,829 [2]. - The total number of authorized shares remains unchanged at 400,000,000 [2][5]. - No fractional shares will be issued; any resulting fractions will be rounded up to the nearest whole share [2][3]. Group 2: Approval and Impact - The reverse stock split was approved by the board of directors with stockholder authority at the 2025 Annual Meeting held on July 23, 2025 [3]. - The split will not affect stockholders' percentage ownership or voting power, aside from minor adjustments for fractional shares [3]. Group 3: Adjustments to Securities - All outstanding options, convertible securities, and other equity instruments will be adjusted accordingly to reflect the reverse stock split [4]. Group 4: Company Overview - DarioHealth Corp. is a leader in the digital health market, focusing on chronic condition management through a user-centric digital therapeutics platform [6][7]. - The platform provides personalized interventions driven by data analytics for conditions such as diabetes, hypertension, and behavioral health [6][7]. Group 5: Market Position - DarioHealth offers its solutions globally to health plans, self-insured employers, and consumers, aiming to disrupt traditional healthcare approaches [8].

Group 1 - Lucid confirmed a 1-for-10 reverse stock split effective August 29, 2025, to improve its share price and maintain Nasdaq compliance [1] - The reverse split will reduce outstanding shares from approximately 3.07 billion to 307.3 million and authorized shares from 15 billion to 1.5 billion [1] - Trading on a split-adjusted basis will commence on September 2, 2025, under the existing ticker symbol [1] Group 2 - AI price prediction models project Lucid's average share price to be $2.05 by August 29, which translates to an adjusted price of around $20.50 post-split [3][4] - The current stock price is $2.06, indicating a slight decrease of 0.24% in the predicted price [4] - All three AI models show a rare alignment in their predictions, reflecting a lack of bullish catalysts for the stock [8] Group 3 - Lucid's market cap has decreased by over 30% in the past six months, now standing at $6.44 billion [8] - The company faces high execution risk due to weak deliveries, significant cash burn, and intense competition in the EV market [9] - While the reverse stock split may provide temporary relief above the $20 level, analysts warn that the stock could decline again without new catalysts [10]

Core Viewpoint - Lucid Group Inc announced a 1-for-10 reverse stock split and a reduction in authorized shares, reflecting ongoing challenges in performance and production guidance [1][2][3]. Group 1: Stock Split and Share Reduction - The reverse stock split will reduce the number of authorized shares from 15 billion to 1.5 billion, effective after market close on August 29, with trading on a split-adjusted basis starting September 2 [2]. - The stock split is occurring as Lucid shares have declined approximately 30% since the beginning of the year [3]. Group 2: Production and Financial Performance - In the second quarter, Lucid produced 3,863 vehicles and delivered 3,309 vehicles, missing analyst estimates on both revenue and earnings [3][4]. - The company has revised its production guidance for 2025, lowering it from approximately 20,000 vehicles to a range of 18,000 to 20,000 vehicles, with expectations for Lucid Gravity production to ramp up in the second half of the year [4]. Group 3: Market Reaction - Following the announcement, Lucid shares were up 0.93% in after-hours trading, priced at $2.11 at the time of publication [7].

Core Viewpoint - Lucid Group, Inc. will implement a 1-for-10 reverse stock split and a corresponding reduction of its authorized shares, following approval from its Board of Directors and stockholders, with the effective date set for August 29, 2025 [1][2][3]. Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of outstanding shares from approximately 3,072.6 million to approximately 307.3 million [3]. - The authorized shares will decrease from 15 billion to 1.5 billion as part of the reverse stock split [3]. - The common stock will begin trading on a split-adjusted basis under the same symbol (LCID) on September 2, 2025 [2][3]. Group 2: Shareholder Information - Registered stockholders will not need to take any action to receive post-split shares, as their positions will be automatically adjusted [4]. - Holders of common stock will receive a cash payment in lieu of any fractional shares resulting from the reverse stock split [3][4]. Group 3: Company Overview - Lucid Group is a technology company based in Silicon Valley, focused on creating advanced electric vehicles, including the award-winning Lucid Air and the new Lucid Gravity [6]. - The company assembles its vehicles in a vertically integrated factory located in Arizona [6].